PT Journal
AU Perez-Calatayud, J
   Ballester, F
   Tedgren, C
   DeWerd, LA
   Papagiannis, P
   Rivard, MJ
   Siebert, FA
   Vijande, J
TI GEC-ESTRO ACROP recommendations on calibration and traceability of HE HDR-PDR photon-emitting brachytherapy sources at the hospital level
SO Radiotherapy and Oncology
JI Radiother. Oncol.
PY 2022
BP 108
EP 117
VL 176
DI 10.1016/j.radonc.2022.09.012
LA English
DE Brachytherapy; High energy; Calibration; Dosimetry; HDR-PDR
AB The vast majority of radiotherapy departments in Europe using brachytherapy (BT) perform temporary implants of high-or pulsed-dose rate (HDR-PDR) sources with photon energies higher than 50 keV. Such techniques are successfully applied to diverse pathologies and clinical scenarios. These recommen-dations are the result of Working Package 21 (WP-21) initiated within the BRAchytherapy PHYsics Quality Assurance System (BRAPHYQS) GEC-ESTRO working group with a focus on HDR-PDR source cal-ibration. They provide guidance on the calibration of such sources, including practical aspects and issues not specifically accounted for in well-accepted societal recommendations, complementing the BRAPHYQS WP-18 Report dedicated to low energy BT photon emitting sources (seeds). The aim of this report is to provide a European-wide standard in HDR-PDR BT source calibration at the hospital level to maintain high quality patient treatments.
ER